Cargando…
Malaria in Children
This review is focused on childhood specific aspects of malaria, especially in resource-poor settings. We summarise the actual knowledge in the field of epidemiology, clinical presentation, diagnosis, management and prevention. These aspects are important as malaria is responsible for almost a quart...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507524/ https://www.ncbi.nlm.nih.gov/pubmed/23205261 http://dx.doi.org/10.4084/MJHID.2012.073 |
_version_ | 1782251076262559744 |
---|---|
author | Schumacher, Richard-Fabian Spinelli, Elena |
author_facet | Schumacher, Richard-Fabian Spinelli, Elena |
author_sort | Schumacher, Richard-Fabian |
collection | PubMed |
description | This review is focused on childhood specific aspects of malaria, especially in resource-poor settings. We summarise the actual knowledge in the field of epidemiology, clinical presentation, diagnosis, management and prevention. These aspects are important as malaria is responsible for almost a quarter of all child death in sub-Saharan Africa. Malaria control is thus one key intervention to reduce childhood mortality, especially as malaria is also an important risk factor for other severe infections, namely bacteraemia. In children symptoms are more varied and often mimic other common childhood illness, particularly gastroenteritis, meningitis/encephalitis, or pneumonia. Fever is the key symptom, but the characteristic regular tertian and quartan patterns are rarely observed. There are no pathognomonic features for severe malaria in this age group. The well known clinical (fever, impaired consciousness, seizures, vomiting, respiratory distress) and laboratory (severe anaemia, thrombocytopenia, hypoglycaemia, metabolic acidosis, and hyperlactataemia) features of severe falciparum malaria in children, are equally typical for severe sepsis. Appropriate therapy (considering species, resistance patterns and individual patient factors) – possibly a drug combination of an artemisinin derivative with a long-acting antimalarial drug - reduces treatment duration to only three days and should be urgently started. While waiting for the results of ongoing vaccine trials, all effort should be made to better implement other malaria-control measures like the use of treated bed-nets, repellents and new chemoprophylaxis regimens. |
format | Online Article Text |
id | pubmed-3507524 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Università Cattolica del Sacro Cuore |
record_format | MEDLINE/PubMed |
spelling | pubmed-35075242012-11-30 Malaria in Children Schumacher, Richard-Fabian Spinelli, Elena Mediterr J Hematol Infect Dis Review Articles This review is focused on childhood specific aspects of malaria, especially in resource-poor settings. We summarise the actual knowledge in the field of epidemiology, clinical presentation, diagnosis, management and prevention. These aspects are important as malaria is responsible for almost a quarter of all child death in sub-Saharan Africa. Malaria control is thus one key intervention to reduce childhood mortality, especially as malaria is also an important risk factor for other severe infections, namely bacteraemia. In children symptoms are more varied and often mimic other common childhood illness, particularly gastroenteritis, meningitis/encephalitis, or pneumonia. Fever is the key symptom, but the characteristic regular tertian and quartan patterns are rarely observed. There are no pathognomonic features for severe malaria in this age group. The well known clinical (fever, impaired consciousness, seizures, vomiting, respiratory distress) and laboratory (severe anaemia, thrombocytopenia, hypoglycaemia, metabolic acidosis, and hyperlactataemia) features of severe falciparum malaria in children, are equally typical for severe sepsis. Appropriate therapy (considering species, resistance patterns and individual patient factors) – possibly a drug combination of an artemisinin derivative with a long-acting antimalarial drug - reduces treatment duration to only three days and should be urgently started. While waiting for the results of ongoing vaccine trials, all effort should be made to better implement other malaria-control measures like the use of treated bed-nets, repellents and new chemoprophylaxis regimens. Università Cattolica del Sacro Cuore 2012-11-06 /pmc/articles/PMC3507524/ /pubmed/23205261 http://dx.doi.org/10.4084/MJHID.2012.073 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Articles Schumacher, Richard-Fabian Spinelli, Elena Malaria in Children |
title | Malaria in Children |
title_full | Malaria in Children |
title_fullStr | Malaria in Children |
title_full_unstemmed | Malaria in Children |
title_short | Malaria in Children |
title_sort | malaria in children |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507524/ https://www.ncbi.nlm.nih.gov/pubmed/23205261 http://dx.doi.org/10.4084/MJHID.2012.073 |
work_keys_str_mv | AT schumacherrichardfabian malariainchildren AT spinellielena malariainchildren |